This indicates that ITGA2 not only contributes to the development of pancreatic cancer, but also has an immunosuppressive effect in the tumor immune microenvironment, which further promotes the progression of pancreatic cancer. This evidence concerns the gene ITGA2 and familial pancreatic carcinoma.